Marshall Wace, LLP Calyxt, Inc. Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.02 - $2.46 $86,265 - $208,052	-84,574 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.06 - $4.05 $43,455 - $85,434	21,095 Added 33.23%	84,574 $180,000
Q3 2021 Nov 15, 2021	BUY	$3.18 - $5.08 $52,040 - $83,134	16,365 Added 34.73%	63,479 $215,000
Q2 2021 Aug 13, 2021	SELL	$3.83 - $6.31 $102,165 - $168,319	-26,675 Reduced 36.15%	47,114 $189,000
Q1 2021 May 17, 2021	BUY	$4.25 - $12.01 $313,603 - $886,205	73,789 New	73,789 $444,000
Q4 2019 Feb 14, 2020	SELL	$3.6 - $7.27 $10,440 - $21,083	-2,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.64 - $12.82 $16,355 - $37,178	2,900 New	2,900 $16,000
Q1 2019 May 14, 2019	SELL	$10.38 - $18.97 $393,246 - $718,678	-37,885 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.33 - $14.99 $353,467 - $567,896	37,885 New	37,885 $392,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.